Impact of Intensive Therapy With Continuous Subcutaneous Insulin Infusion on Quality of Life in Patients With Type 1 Diabetes

被引:2
作者
Anarte Ortiz, Maria Teresa [1 ]
Caballero Diaz, Francisco Felix [1 ]
Romero, Alberto Machado [2 ]
Ruiz de Adana Navas, Maria Soledad [3 ]
Dominguez-Lopez, Marta [3 ]
Gonzalo-Marin, Montserrat [3 ]
Tapia Guerrero, Maria Jose [3 ]
Valdes Hernandez, Sergio [3 ]
Gonzalez-Romero, Stella [3 ]
Rojo-Martinez, Gemma [3 ]
Casimiro-Soriguer Escofet, Federico J. [3 ]
机构
[1] Punta de Europa Hosp Algeciras, Mental Hlth Dept, Algeciras, Spain
[2] Hosp Punta Europa, Algeciras, Spain
[3] Carlos Haya Reg Univ Hosp Malaga, Endocrinol Dept, Malaga, Spain
关键词
D O I
10.1111/j.1751-9861.2010.00049.x
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The purpose of this research was to study the effects of treatment with continuous subcutaneous insulin infusion (CSII) on quality of life in patients with type 1 diabetes. A quasi-experimental pretest-posttest design was used. Thirty-seven patients were evaluated before and after receiving treatment. The Diabetes Quality of Life Questionnaire, Beck Depression Inventory-II, State-Trait Anxiety Inventory, and Multidimensional Health Locus of Control Scale were applied. Patients treated with CSII reported a significant improvement in their quality of life (better total quality of life, higher diabetes life satisfaction, and less social and vocational concerns) when compared with patients with Multiple Daily Injections. Although some limitations are described, the results of this study show some evidence of positive effect of pump therapy in patients with poor glycemic control prior to pump start.
引用
收藏
页码:1 / 19
页数:19
相关论文
共 47 条
[1]  
Anarte M. T., 2009, AVANCES DIABETOLOGIA, V25, P394
[2]   Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes [J].
Barnard, K. D. ;
Lloyd, C. E. ;
Skinner, T. C. .
DIABETIC MEDICINE, 2007, 24 (06) :607-617
[3]  
Bell D S, 2000, Endocr Pract, V6, P357
[4]   Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes [J].
Bode, BW ;
Steed, RD ;
Davidson, PC .
DIABETES CARE, 1996, 19 (04) :324-327
[5]   Continuous subcutaneous insulin infusion - A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes [J].
Boland, EA ;
Grey, M ;
Oesterle, A ;
Fredrickson, L ;
Tamborlane, WV .
DIABETES CARE, 1999, 22 (11) :1779-1784
[6]   Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes [J].
Bott, U ;
Mühlhauser, I ;
Overmann, H ;
Berger, M .
DIABETES CARE, 1998, 21 (05) :757-769
[7]   Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life [J].
Bruttomesso, D ;
Pianta, A ;
Crazzolara, D ;
Scaldaferri, E ;
Lora, L ;
Guarneri, G ;
Mongillo, A ;
Gennaro, R ;
Miola, M ;
Moretti, M ;
Confortin, L ;
Beltramello, GP ;
Pais, M ;
Baritussio, A ;
Casiglia, E ;
Tiengo, A .
DIABETIC MEDICINE, 2002, 19 (08) :628-634
[8]  
Cella D. F., 1999, AM ACAD NEUROLOGY, V47, P129
[9]   Effect of patient-selected intensive insulin therapy on quality of life [J].
Chantelau, E ;
Schiffers, T ;
Schutze, J ;
Hansen, B .
PATIENT EDUCATION AND COUNSELING, 1997, 30 (02) :167-173
[10]  
Chorot P., 1995, ESCALA MULTIDIMENSIO